Quantamental Technologies LLC Acadia Pharmaceuticals Inc Transaction History

Quantamental Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $207,708 - $299,309	11,669 New	11,669 $279,000
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $493,834 - $683,354	-12,033 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $438,241 - $685,881	12,033 New	12,033 $496,000
Q3 2019 Nov 08, 2019	SELL	$22.22 - $44.01 $47,328 - $93,741	-2,130 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$23.32 - $28.12 $49,671 - $59,895	2,130 New	2,130 $57,000

315

164M

855K

350K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.77B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.